With Every Kid Healthy Week kicking off today, the personal-finance website WalletHub today released its report on 2017’s Best & Worst States for Children’s Health Care. In order to determine...

Last week, Florida Governor Rick Scott directed the Department of Children and Families (DCF), the Department of Health (DOH) and the Florida Department of Law Enforcement (FDLE) to meet with communities...

Recognized for easing psoriasis symptoms of dry, itchy, flaky skin, five products have recently been awarded the National Psoriasis Foundation (NPF) Seal of Recognition. The NPF Seal of Recognition highlights...

A new report from the American Society of Plastic Surgeons (ASPS) reveals that Americans spent more than ever before – $16 billion – on cosmetic plastic surgery and minimally-invasive procedures...

GlaxoSmithKline (GSK) has voluntarily recalled 593,088 Ventolin HFA (albuterol sulfate) inhalers due to an issue with the delivery system. According to the US Food and Drug Administration (FDA), there...

Scott Gottlieb, the physician and entrepreneur who is President Trump’s nominee to head the Food and Drug Administration, told senators Wednesday that the nation’s opioid crisis is a “public...

Five simple medical tests together provide a broader and more accurate assessment of heart-disease risk than currently used methods, cardiologists at UT Southwestern Medical Center found. Combined, results...

Heroin use and heroin use disorder have increased significantly among American adults since 2001, according to new research conducted at Columbia University’s Mailman School of Public Health. The...

On March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS)....

The U.S. Food and Drug Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for patients whose eczema is...